First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
Cytokine. 2019 Aug;120:125-129. doi: 10.1016/j.cyto.2019.04.017. Epub 2019 May 4.
We previously reported that the cytokine profiles in the bronchoalveolar lavage fluid (BALF) of IgG4-related respiratory disease (IgG4-RRD) more closely resemble the T-helper (Th) 2 response than sarcoidosis. The present study aimed to assess the chemokines in the BALF of IgG4-RRD and sarcoidosis in order to evaluate any possible associations between these chemokines and other markers.
We examined 12 chemokines using a MILLIPLEX® MAP Kit (Millipore, Darmstadt, Germany) in the same BALF samples of the same 44 patients (IgG4-RRD, n = 11; sarcoidosis, n = 33) in which we had previously evaluated the cytokines.
The levels of CC-chemokine ligand (CCL)26 in the BALF of IgG4-RRD patients (median 24.5, range 3.1-401.1 pg/mL) were significantly higher than those in the BALF of sarcoidosis patients (median 3.1, range 3.1-155.6 pg/mL, p < 0.05). Interestingly, the BALF levels of CCL1 in the sarcoidosis patients (median 13.1, range 0.1-106.9 pg/mL) were significantly higher than those of the IgG4-RRD patients (median 9.8, range 0.1-14.7 pg/mL, p < 0.05). Furthermore, the CCL1 levels in the BALF were correlated with the total cell count (ρ = 0.539, p < 0.001), lymphocyte fraction (R = 0.406, P < 0.05), lymphocyte count (R = 0.686, P < 0.001), TNF-α level, (R = 0.748, P < 0.001), and IL-2 level (R = 0.757, P < 0.001) in the BALF of sarcoidosis patients.
CCL1 might reflect disease activity and its involvement in the pathogenesis of sarcoidosis might be more closely related to Th1 than to Th2.
我们之前的研究报告显示,IgG4 相关呼吸系统疾病(IgG4-RRD)患者支气管肺泡灌洗液(BALF)中的细胞因子谱更类似于辅助性 T 细胞(Th)2 反应,而不是结节病。本研究旨在评估 IgG4-RRD 和结节病患者 BALF 中的趋化因子,以评估这些趋化因子与其他标志物之间的任何可能关联。
我们使用 MILLIPLEX® MAP 试剂盒(Millipore,达姆施塔特,德国)在之前评估过细胞因子的 44 名相同患者(IgG4-RRD,n=11;结节病,n=33)的相同 BALF 样本中检测了 12 种趋化因子。
IgG4-RRD 患者 BALF 中的 C 型趋化因子配体(CCL)26 水平(中位数 24.5,范围 3.1-401.1 pg/mL)明显高于结节病患者 BALF 中的水平(中位数 3.1,范围 3.1-155.6 pg/mL,p<0.05)。有趣的是,结节病患者 BALF 中的 CCL1 水平(中位数 13.1,范围 0.1-106.9 pg/mL)明显高于 IgG4-RRD 患者(中位数 9.8,范围 0.1-14.7 pg/mL,p<0.05)。此外,BALF 中的 CCL1 水平与总细胞计数(ρ=0.539,p<0.001)、淋巴细胞分数(R=0.406,P<0.05)、淋巴细胞计数(R=0.686,P<0.001)、TNF-α 水平(R=0.748,P<0.001)和 IL-2 水平(R=0.757,P<0.001)呈正相关。
CCL1 可能反映疾病活动度,其在结节病发病机制中的作用可能与 Th1 更为密切相关,而不是 Th2。